These aggressiveness properties of GBM may be controlled through IRE1 signaling as the sequencing of the IRE1 gene (ERN1) in GBM samples revealed a somatic A414T mutation correlating with high vascularization and strong XBP1s staining. Here, ERN1 is linked to glioblastoma.